Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JORI S CARTER

Allopathic & Osteopathic Physicians Obstetrics & Gynecology Gynecologic Oncology

NPI
1780859298
CMS profile
171740
Location
NORTH CHESTERFIELD, VA

General Payments · PY2018–2024

$4,856.15

  • Reported across 107 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,505.35

33 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Long term medical supply or device loan $797.60 8
Food and Beverage $707.75 25

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $223.37 14
PY2019 $1,815.40 10
PY2020 $101.20 6
PY2021 $410.83 13
PY2022 $340.72 16
PY2023 $459.28 15
PY2024 $1,505.35 33

Payment records · PY2024 (33)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $29.00 03/27/2024 Food and Beverage Undisputed 01/23/2026 1103422879 CMS
ABBVIE INC. $27.37 07/30/2024 Food and Beverage Undisputed 01/23/2026 1103422881 CMS
ABBVIE INC. $33.75 09/17/2024 Food and Beverage Undisputed 01/23/2026 1103422883 CMS
ABBVIE INC. $29.91 11/26/2024 Food and Beverage Undisputed 01/23/2026 1103422885 CMS
Astellas Pharma US Inc $20.00 12/05/2024 Food and Beverage Undisputed 01/23/2026 1139441824 CMS
AstraZeneca Pharmaceuticals LP $31.08 09/26/2024 Food and Beverage Undisputed 01/23/2026 1104453438 CMS
AstraZeneca Pharmaceuticals LP $30.37 10/01/2024 Food and Beverage Undisputed 01/23/2026 1104785906 CMS
AstraZeneca Pharmaceuticals LP $124.99 11/19/2024 Food and Beverage Undisputed 01/23/2026 1126677526 CMS
AstraZeneca Pharmaceuticals LP $1.42 12/13/2024 Food and Beverage Undisputed 01/23/2026 1104211899 CMS
AstraZeneca Pharmaceuticals LP $27.62 12/13/2024 Food and Beverage Undisputed 01/23/2026 1105416120 CMS
Cumberland Pharmaceuticals, Inc. $14.72 11/07/2024 Food and Beverage Undisputed 01/23/2026 1146399938 CMS
Eisai Inc. $25.39 09/03/2024 Food and Beverage Undisputed 01/23/2026 1110755000 CMS
GlaxoSmithKline, LLC. $34.86 08/29/2024 Food and Beverage Undisputed 01/23/2026 1116255841 CMS
GlaxoSmithKline, LLC. $23.25 10/28/2024 Food and Beverage Undisputed 01/23/2026 1115959671 CMS
GlaxoSmithKline, LLC. $28.81 12/11/2024 Food and Beverage Undisputed 01/23/2026 1116466834 CMS
ImmunoGen, Inc. $28.67 01/30/2024 Food and Beverage Undisputed 01/23/2026 1099941423 CMS
Merck Sharp & Dohme LLC $22.71 02/01/2024 Food and Beverage Undisputed 01/23/2026 1141807543 CMS
Merck Sharp & Dohme LLC $22.16 08/19/2024 Food and Beverage Undisputed 01/23/2026 1141807541 CMS
Merck Sharp & Dohme LLC $19.11 09/19/2024 Food and Beverage Undisputed 01/23/2026 1141903856 CMS
Merck Sharp & Dohme LLC $16.79 11/05/2024 Food and Beverage Undisputed 01/23/2026 1141807671 CMS
Novartis Pharmaceuticals Corporation $34.93 02/15/2024 Food and Beverage Undisputed 01/23/2026 1086761645 CMS
Novartis Pharmaceuticals Corporation $99.70 05/16/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086761659 CMS
Novartis Pharmaceuticals Corporation $99.70 06/13/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086761661 CMS
Novartis Pharmaceuticals Corporation $99.70 07/15/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086761663 CMS
Novartis Pharmaceuticals Corporation $99.70 08/23/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086761655 CMS
Novartis Pharmaceuticals Corporation $99.70 09/27/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086761657 CMS
Novartis Pharmaceuticals Corporation $99.70 10/17/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086761667 CMS
Novartis Pharmaceuticals Corporation $99.70 11/14/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086761665 CMS
Novartis Pharmaceuticals Corporation $99.70 12/10/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086761671 CMS
PFIZER INC. $19.05 10/09/2024 Food and Beverage Undisputed 01/23/2026 1130992239 CMS
Sumitomo Pharma America, Inc. $16.48 01/08/2024 Food and Beverage Undisputed 01/23/2026 1148835669 CMS
Sumitomo Pharma America, Inc. $23.36 11/21/2024 Food and Beverage Undisputed 01/23/2026 1148835671 CMS
Tempus AI, Inc $21.95 04/08/2024 Food and Beverage Undisputed 01/23/2026 1150162145 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.